--- a
+++ b/clusters/9knumclustersv2/clust_1496.txt
@@ -0,0 +1,94 @@
+Total bilirubin =< . x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . X institutional upper limit of normal (ULN) (except subjects with Gilbert syndrome, who can have total bilirubin <  mg/dL) must be obtained =<  days prior to protocol registration
+Total bilirubin =< . x institutional upper limit of normal (IULN) (except Gilbert's syndrome, who must have a total bilirubin < . mg/dL)
+Serum bilirubin ? . x ULN, except in subjects with Gilbert's Syndrome who must have a total bilirubin <  mg/dL
+Total bilirubin ? . mg/dL (upper limit of normal) except subject with documented Gilbert's syndrome (?  x ULN) or liver metastasis, who must have a baseline total bilirubin ? . mg/dL
+Obtained within  days prior to CD: Total Bilirubin =< . x ULN, except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL
+Bilirubin less than or equal to . x the upper limit of normal (except subjects with Gilbert syndrome, who can have total bilirubin <  mg/dl)
+Bilirubin ? x ULN (except subjects with Gilbert's syndrome, who must have total bilirubin < . mg/dL (< mol/L))
+Bilirubin (total) within normal institutional limits (except subjects with Gilbert syndrome who must have total bilirubin < . mg/dL)
+Total bilirubin should be =<  x upper limit of normal (ULN) (patients with Gilbert's syndrome must have a total bilirubin less than . mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who must have total bilirubin < . mg/dL) within  days prior to first dose of protocol-indicated treatment.
+Within  days of the first dose of study drug: Total bilirubin =< . x ULN (except patients with Gilbert syndrome who must have total bilirubin < . mg/dL)
+Bilirubin =< . x ULN (except subjects with Gilbert Syndrome, who can have total bilirubin < . mg/dL).
+Obtained within  days prior to registration: Bilirubin =< . x upper limit of normal (ULN) (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin < . x institutional normal limits (subjects with known Gilbert syndrome are eligible with total bilirubin < . mg/dL).
+Obtained within  days prior to randomization/registration: total Bilirubin =< . x ULN (except subjects with Gilbert Syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Bilirubin less than or equal to . x the upper limit of normal (except subjects with Gilbert syndrome, who can have total bilirubin <  mg/dl)
+Total bilirubin =< . x ULN (upper limit of normal) except subject with documented Gilbert's syndrome (=<  x ULN) or liver metastasis, who must have a baseline total bilirubin =< . mg/dL
+Bilirubin less than or equal to . x the upper limit of normal (except subjects with Gilbert syndrome, who can have total bilirubin <  mg/dl)
+Total bilirubin =< . x ULN (except subjects with Gilbert Syndrome, who can have total bilirubin < . mg/dL) within  days of registration
+Total bilirubin =<  mg/dL or direct bilirubin =< ULN for those with total bilirubin >  x ULN; subjects with Gilbert syndrome will be eligible if total bilirubin is < . mg/dL
+Total bilirubin =< . x ULN within  days of study registration (except subjects with Gilbert Syndrome who must have total bilirubin < . mg/dl).
+Obtained within  days prior to randomization/registration: Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL).
+Total bilirubin =< . x upper limit of normal (ULN) (except subjects with Gilbert syndrome who can have total bilirubin < . mg/dL)
+Bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x institutional upper limit of normal (ULN), except patients with Gilbert's syndrome in whom total bilirubin must be < . mg/dL, within  weeks of registration (except where specified otherwise)
+Total bilirubin (Bili T) =< . x ULN (although patients with Gilbert syndrome can have total bilirubin < . mg/dL), within  days before study registration
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL) within  days prior to first dose
+Serum total bilirubin =< . x ULN (subjects with Gilbert syndrome can have a total bilirubin <  mg/dL), performed within  days of protocol registration
+Obtained within  days of randomization: Total bilirubin =< . x ULN (except subjects with Gilbert Syndrome who must have total bilirubin < . mg/dL)
+Total bilirubin > . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x upper limit of normal (ULN) (except patients with Gilbert Syndrome, who can have total bilirubin < . mg/dL)
+FULL STUDY INCLUSION CRITERIA: Total bilirubin =< . x the upper limit of normal (ULN); documented Gilbert syndrome is allowed if total bilirubin is mildly elevated (<  mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Serum total bilirubin =< . X ULN OR except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL
+Total bilirubin =< . x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL), within  days prior to treatment
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL) or =<  x ULN if lenalidomide is being prescribed; should be obtained within  days prior to enrollment
+Bilirubin ? . x ULN, (except patients with Gilbert's Syndrome, who must have a total bilirubin less than . mg/dL)
+Total Bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . times the institutional upper limit of normal (ULN) (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . mg/dL x upper limit of normal (ULN) (except subjects with Gilbert syndrome who can have total bilirubin =< . mg/dL)
+Total bilirubin < . X institutional normal limits (subjects with known Gilbert syndrome are eligible with total bilirubin < . mg/dL)
+Total bilirubin =< . x ULN; except subjects with Gilbert syndrome who can have total bilirubin < . mg/dL) obtained within  days of first treatment
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL) obtained within  days prior to randomization/registration
+Total bilirubin =< . x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total serum bilirubin =< . x upper limit of normal (ULN) (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . X normal institutional limits (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Within  days prior to study entry: Bilirubin =< . x upper limit of normal (ULN); except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin within normal institutional limits (patients with Gilbert's syndrome must have a total bilirubin < . mg/dL)
+Total bilirubin ? . x upper limit of normal (ULN) (except patients with Gilbert Syndrome, who can have total bilirubin < . mg/dL)
+Serum total bilirubin =< . x institutional upper limit of normal (ULN) (patients with Gilbert's syndrome with a total bilirubin < . mg/dL)
+Total bilirubin\r\n* If no known liver metastases:\r\n** Total bilirubin =< . x institutional upper limit of normal (ULN) (except subjects with Gilbert syndrome, who may have total bilirubin < . mg/dl)\r\n* If known metastasis:\r\n** Total bilirubin =<  ULN
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Bilirubin less than or equal to . x the upper limit of normal (except subjects with Gilbert syndrome, who can have total bilirubin <  mg/dl)
+Obtained within  days prior to registration: Bilirubin . =< (ULN)\r\n* Except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL
+Total bilirubin =< . x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Bilirubin =<  x ULN (except subjects with Gilbert syndrome who must have total bilirubin < . mg/dL)
+Total bilirubin ? . upper limit of normal (ULN), except for participants with Gilbert's syndrome as defined by > % unconjugated bilirubin and total bilirubin ?  mg/dL
+Serum total bilirubin > .  ULN or > . mg/dL for subjects with documented Gilbert's syndrome
+Bilirubin within normal limits (except subjects with Gilbert's syndrome, who must have a total bilirubin < . mg/dL)
+Total bilirubin ?  x ULN, (except patients with Gilbert's Syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert Syndrome who must have total bilirubin < . mg/dL)
+Total bilirubin =< . x ULN (<  mg/dL for subjects with Gilbert's disease)
+Total bilirubin ? .  ULN (except in patients with Gilbert Syndrome who can have total bilirubin < . mg/dL).
+Serum bilirubin ? . x ULN, except in patients with Gilbert's Syndrome who must have a total bilirubin <  mg/dL
+Total bilirubin =< . x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< ULN (except subjects with Gilbert syndrome who must have total bilirubin < . mg/dl)
+Serum total bilirubin <  x ULN (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x institutional upper limit of normal (ULN) (except patients with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin levels ? . x upper limit of normal [ULN] (except for patients with Gilbert's Syndrome, who must have a total bilirubin of less than . mg/dL)
+Total bilirubin =< upper limit of normal (ULN) except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL
+Bilirubin =< . x ULN, (except patients with Gilbert's syndrome, who must have a total bilirubin less than . mg/dL)
+Serum bilirubin =< . times the upper institutional limits of normal (ULN); patients with a history of Gilbert's syndrome may be enrolled if the total bilirubin is <  mg/dL with a predominance of indirect bilirubin
+COHORT A: Bilirubin =< . x ULN (except patients with Gilbert's syndrome, who must have a total bilirubin less than . mg/dL)
+COHORT B: Bilirubin =< . x ULN (except patients with Gilbert's syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin within normal institutional limits; for patients with Gilbert's syndrome, total bilirubin =< . mg/dL
+Total Bilirubin >.x ULN (except subjects with Gilbert syndrome, total bilirubin <. mg/dL)
+Total bilirubin =< . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin ?. x ULN, except in patients with Gilbert's Syndrome who must have a total bilirubin < mg/dL (. ?mol/L)
+Total bilirubin <. x ULN, except for patients with Gilbert's disease who are eligible if total bilirubin ? mg/dL.
+Adequate hepatic and renal function laboratory values within  days prior to registration: Total bilirubin =< . mg/dL except for patients with a history of elevated total bilirubin, such as in Gilbert's
+Total bilirubin =<  x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin =< . x the upper limit of normal (ULN); for subjects with known Gilbert's disease, bilirubin =< . mg/dL
+Total bilirubin < . x ULN (except subjects with Gilbert syndrome who can have total bilirubin < . mg/deciliter) should be obtained with  days prior to randomization
+Total bilirubin ? .  ULN except subjects with documented Gilbert's syndrome (>   ULN) or liver metastasis, who must have a baseline total bilirubin ? . mg/
+Total bilirubin ? . x the upper limit of normal (ULN). Mildly elevated total bilirubin (<  mg/dL) is allowed if Gilbert's syndrome is documented.
+Bilirubin =< . x ULN (except patients with Gilbert's syndrome, who must have a total bilirubin less than . mg/dL)
+Total bilirubin =< . x ULN; (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)
+Total bilirubin ? . x ULN (except subjects with Gilbert syndrome, who can have total bilirubin < . mg/dL)